What is Biogen Pharmachem Industries Ltd (531752) share price return in the past 10 years?

Biogen Pharmachem Industries Ltd share price has appreciated 9.9% annually (CAGR) over the past ten years.

What is the share price of Biogen Pharmachem Industries Ltd (531752)?

Company share prices are keep on changing according to the market conditions. The current trading price of Biogen Pharmachem Industries Ltd (531752) on 10-Apr-2026 16:59:59 at 16:59 is 0.49.

What is the P/E ratio of Biogen Pharmachem Industries?

The latest standalone P/E ratio of Biogen Pharmachem Industries as of 10-Apr-2026 is 17.73.

What is the P/B ratio of Biogen Pharmachem Industries Ltd (531752)?

The latest standalone P/B ratio of Biogen Pharmachem Industries Ltd (531752) as of 10-Apr-2026 is 0.44.

What is the 52-week high and low of Biogen Pharmachem Industries Ltd (531752)?

The 52-week high of Biogen Pharmachem Industries Ltd (531752) is Rs. 1.08 and the 52-week low is Rs. 0.48.

Biogen Pharmachem Industries Ltd (531752) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Biogen Pharmachem Industries Ltd (531752)
Brand: Biogen Pharmachem Industries

Biogen Pharmachem Industries Ltd (531752) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹44 Cr.

P/E Ratio

17.73

Price to Book (P/B)

0.44

Price to Sales (P/S)

0.00

EV/EBITDA

17.58

Return on Capital Employed (ROCE)

-0.36%

Current Price

₹0.5

Return on Equity (ROE)

-0.52%

Return on Assets (ROA)

-0.39%

Operating Profit Margin

Net Profit Margin

-INF%

Gross Profit Margin

Book Value per Share

₹1.1

Sales Growth (YoY)

NA%

Sales Growth (3 Years)

-100%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-115.03%

52-Week Low / High

₹0 / 1

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

0.00%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1

Biogen Pharmachem Industries Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Gross Profit margin of Biogen Pharmachem Industries Ltd?

Biogen Pharmachem Industries Ltd Gross profit margin which is the profit after deduction of direct costs, is 0% for FY-2025 , which is in line with its 5 year median of 0% , indicating stable margins.

Q.1 Promoter shareholding and pledge status of Biogen Pharmachem Industries Ltd?

Promoters hold 0.00% of the Biogen Pharmachem Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Biogen Pharmachem Industries Ltd vs industry peers?

Biogen Pharmachem Industries Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 17.75% , indicating slower growth and losing its market share.

Q.1 Stock return of Biogen Pharmachem Industries Ltd over the last decade?

Over the last 9 years, the stock has delivered a CAGR of 9.4% based on the current price.

Q.1 Is Biogen Pharmachem Industries Ltd a good quality company?

Biogen Pharmachem Industries Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Biogen Pharmachem

Based on:

Data

M-Cap below 100cr DeciZen not available

Biogen Pharmachem Industries stock performance

Key Ratios

Is Biogen Pharmachem Industries Ltd an attractive stock to invest in?

1. Is Biogen Pharmachem Industries Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biogen Pharmachem Industries Ltd is a below average quality company.

2. Is Biogen Pharmachem Industries Ltd undervalued or overvalued?

The key valuation ratios of Biogen Pharmachem Industries Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Biogen Pharmachem Industries Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biogen Pharmachem Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-0%	-0.2%	-11.3%	-0%	-0.2%	-2.9%	-0%	0.8%	3.5%	-0.4%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.8	-1.0	-1.0	-1.2	-1.0	-0.9	-0.8	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	1	0	1.6	2.5	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	-100%	NA	52.5%	-100%	NA	NA	-
Adj EPS ⓘ	-0	-0	-0	-0	-0	-0	0	-0	0	-0	0
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	-100%	-
BVPS (₹) ⓘ	0.9	0.9	0.8	0.8	0.9	0.8	0.8	0.8	0.9	0.9	1.1
Adj Net Profit ⓘ	-0	-0.1	-1.9	-0	-0.1	-0.5	0.2	-0	0.8	-0	3
Cash Flow from Ops. ⓘ	4.7	-0.1	-13.7	0.1	-1.2	4	1.4	1.7	1.9	-1.1	-
Debt/CF from Ops. ⓘ	1.3	-10.8	-0	7.2	-0.3	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-100%	NA
Adj EPS ⓘ	NA	NA	NA	-100%
BVPSⓘ	-0.9%	0.2%	1.2%	-1.2%
Share Price	9.9%	11.1%	-11.6%	-47.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-0.1	-0.2	-3.3	-0	-0.2	-0.9	0.4	-0	1.5	-0.1	3.1
Op. Profit Mgn % ⓘ	0	0	0	-0.4	0	0.3	12	0	0	0	NAN
Net Profit Mgn % ⓘ	0	0	0	-0.4	0	-29.4	8.5	0	0	0	INF
Debt to Equity ⓘ	0.1	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	0	0	19,937	0	10,617	6,835	0	0	0	0
Cash Conv. Cycle ⓘ	0	0	0	2,683	0	1,181	182	0	0	0	0

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 3.10%

Sales growth has been subdued in last 3 years -100.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹) ⓘ	1.1	-
Reserves (₹ Cr.) ⓘ	9	-
P/BV ⓘ	0.44	-
PE ⓘ	17.73	-

From the Market
52 Week Low / High (₹)	0.48 / 1.08
All Time Low / High (₹)	0.02 / 18.70
Market Cap (₹ Cr.)	44.2
Equity (₹ Cr.)	90.3
Face Value (₹)	1
Industry PE ⓘ	24.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Biogen Pharmachem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0.95	0	1.62	2.47	0	0	0
Operating Expenses ⓘ +	0.03	0.12	6.72	0.95	0.12	3.23	2.49	0.46	0.45	1.47
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0.91	0	1.48	2.01	0	0	0
Employee Cost	0	0.01	0.03	0.04	0.04	0.01	0.05	0.17	0.08	0.17
Other Costs ⓘ	0.03	0.11	6.69	0.01	0.08	1.73	0.42	0.28	0.37	1.30
Operating Profit ⓘ	-0.03	-0.12	-6.72	-0	-0.12	-1.60	-0.02	-0.46	-0.45	-1.47
Operating Profit Margin (%)	-	-	-	-0.4%	-	-98.8%	-0.6%	-	-	-
Other Income ⓘ +	0	0	0.15	0	0	0	0.01	0.91	2.38	1.20
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.03	-0.12	-6.56	-0	-0.12	-1.60	-0.01	0.46	1.93	-0.27
Tax ⓘ	0	0	0	0	0	0	0	0	0	0.02
Profit After Tax	-0.03	-0.12	-6.56	-0	-0.12	-1.60	-0.01	0.46	1.93	-0.29
PAT Margin (%)	-	-	-	-0.4%	-	-98.8%	-0.4%	-	-	-
Adjusted EPS (₹)	0.0	0.0	-0.1	0.0	0.0	-0.0	0.0	0.0	0.0	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	60.96	60.84	54.28	54.27	55.75	54.14	54.13	54.59	56.52	56.23
Share Capital ⓘ	65.26	65.26	65.26	65.26	65.26	65.26	65.26	65.26	65.26	65.26
Reserves ⓘ	-4.30	-4.42	-10.98	-10.99	-9.51	-11.12	-11.13	-10.67	-8.74	-9.03
Debt +	6.21	0.72	0.01	0.63	0.31	0	0	0	0	0
Long Term Debt	6.21	0.72	0.01	0.63	0.31	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	1.09	0	0.06	0	0	0	0
Others Liabilities ⓘ	1.64	1.69	1.64	1.64	0.04	0.05	0.82	0.24	0.30	35.79
Total Liabilities ⓘ	68.81	63.25	55.93	57.63	56.09	54.25	54.95	54.83	56.82	92.02
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0	0	0	0	0	0
Gross Block	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	26.69	22.39	3.52	6.25	6.45	9.49	6.95	8.85	5.44	23.84
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0	0	7.03	8.03	8.03	2.54	0	0	0	0
Cash Equivalents	0.13	0.06	0.02	0	0	0.01	0.08	0.13	0.02	2.02
Others Assets ⓘ	41.98	40.79	45.36	43.35	41.62	42.21	47.91	45.85	51.36	66.16
Total Assets ⓘ	68.81	63.25	55.93	57.63	56.09	54.25	54.95	54.83	56.82	92.02

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	4.68	-0.07	-13.65	0.09	-1.21	3.95	1.40	1.70	1.94	-1.08
PBT ⓘ	-0.03	-0.12	-6.56	-0	-0.12	-1.60	-0.01	0.46	1.93	-0.29
Adjustment ⓘ	0	0	0	0	0	0	0	0	0	0
Changes in Working Capital ⓘ	4.71	0.05	-7.08	0.09	-1.1	5.55	1.41	1.25	0.01	-0.79
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	17.08	4.30	14.32	-0.72	1.54	-3.64	-1.32	-1.66	-2.06	-32.62
Capex	0	0	0	0	0	0	0	0	0	0
Net Investments	17.08	4.30	18.88	-2.73	-0.20	-3.04	2.54	-1.90	3.41	-18.40
Others ⓘ	0	0	-4.56	2.01	1.74	-0.60	-3.86	0.24	-5.47	-14.22
Cash Flow From Financing Activity ⓘ +	-21.74	-4.31	-0.71	0.62	-0.32	-0.31	0	0	0	35.70
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-1.45	1.18	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-20.29	-5.49	-0.71	0.62	-0.32	-0.31	0	0	0	35.70
Net Cash Flow ⓘ	0.02	-0.07	-0.03	-0.02	0	0	0.08	0.05	-0.11	2

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-0.05	-0.2	-11.4	-0.01	-0.21	-2.92	-0.02	0.84	3.48	-0.52
ROCE (%)	-0.04	-0.19	-11.33	-0.01	-0.21	-2.91	-0.02	0.84	3.48	-0.36
Asset Turnover Ratio	0	0	0	0.02	0	0.03	0.05	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	3.7	1.01	N/A
Working Capital Days
Receivable Days	0	0	0	2,893	0	1,188	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	219	0	15	0	0	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biogen Pharmachem Industries Ltd FAQs

The current trading price of Biogen Pharmachem on 10-Apr-2026 16:59 is ₹0.49.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Biogen Pharmachem stood at ₹44.23 Cr

The latest P/E ratio of Biogen Pharmachem as of 09-Apr-2026 is 17.73.

The latest P/B ratio of Biogen Pharmachem as of 09-Apr-2026 is 0.44.

The 52-week high of Biogen Pharmachem is ₹1.08 and the 52-week low is ₹0.48.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biogen Pharmachem is ₹0.00 ( Cr.) .

About Biogen Pharmachem Industries Ltd

Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.

The company is engaged in the business of trading in shares and securities, small level of stock broking and consulting works. As of March 31, 2009, the company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets.

The company is also diversifying its business activities in the power sector, by establishing wind power generation plant.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Biogen Pharmachem Industries Ltd (531752) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Biogen Pharmachem Share Price